Growth Metrics

Microbot Medical (MBOT) EBIT Margin (2016)

Historic EBIT Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 5737.96%.

  • Microbot Medical's EBIT Margin rose 212345800.0% to 5737.96% in Q3 2016 from the same period last year, while for Sep 2016 it was 25453.42%, marking a year-over-year decrease of 215457100.0%. This contributed to the annual value of 31415.32% for FY2015, which is N/A changed from last year.
  • Latest data reveals that Microbot Medical reported EBIT Margin of 5737.96% as of Q3 2016, which was up 212345800.0% from 30309.28% recorded in Q2 2016.
  • In the past 5 years, Microbot Medical's EBIT Margin ranged from a high of 826.99% in Q1 2012 and a low of 42674.62% during Q1 2015
  • Its 5-year average for EBIT Margin is 18705.6%, with a median of 18852.32% in 2013.
  • Per our database at Business Quant, Microbot Medical's EBIT Margin plummeted by -282068700bps in 2015 and then skyrocketed by 212345800bps in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's EBIT Margin stood at 2917.39% in 2012, then tumbled by -582bps to 19907.16% in 2013, then skyrocketed by 94bps to 1101.83% in 2014, then crashed by -2560bps to 29308.7% in 2015, then soared by 80bps to 5737.96% in 2016.
  • Its EBIT Margin was 5737.96% in Q3 2016, compared to 30309.28% in Q2 2016 and 42366.93% in Q1 2016.